diltiazem

Also found in: Medical.
(redirected from Tiazac)

dil·ti·a·zem

 (dĭl-tī′ə-zĕm′)
n.
A calcium channel blocker drug, C22H26N2O4S, that acts as a coronary vasodilator and is used in the form of its hydrochloride to treat angina pectoris and hypertension.

[(vaso)dil(ator) + -tiazem, suff. for calcium channel blockers (shortening and alteration of benzothiazepine, class of compounds : benzo- + thi(o)- + az(o)- + ep(oxide) + -ine).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

diltiazem

(dɪlˈtaɪəˌzɛm)
n
(Pharmacology) a benzothiapine and a calcium channel blocker, used to treat angina and arrhythmia
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.diltiazem - a calcium blocker (trade name Cardizem) used in treating hypertension or angina or heart failure
calcium blocker, calcium-channel blocker - any of a class of drugs that block the flow of the electrolyte calcium (either in nerve cell conduction or smooth muscle contraction of the heart); has been used in the treatment of angina or arrhythmia or hypertension or migraine
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

diltiazem

n diltiazem m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in
References in periodicals archive
That component includes such medicines as the dermatologic treatment Aldara, the hypertension medication Tiazac and the diabetes drug Glumetza.
Some commonly prescribed drugs in this class include verapamil (Isoptin, Verelan, Calan) and diltiazem (Cardizem, Tiazac).
18 November 2010 - India-based speciality pharmaceuticals company Sun Pharmaceutical Industries Ltd (BOM: 524715) announced today that the US Food and Drug Administration (FDA) has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac extended release capsules.
In addition, if combined with Sustiva, the following drugs may require a change in the dose of either Sustiva or the other medicine: Ritadin (ritampin); Sporanox (itraconazole); Nizoral (ketoconazole); calcium-channel blockers (for example, Cardizem, Tiazac, and others); and the cholesterol-lowering medications Lipitor (atorvastatin), Pravachol (pravastatin), and Zocor (simvastatin).
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.